| Dr John L Kluthe, PH D | |
|
4699 Harrison Blvd Ste 300, Ogden, UT 84403-4368 | |
| (801) 479-8286 | |
| (801) 479-8247 |
| Full Name | Dr John L Kluthe |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Cognitive & Behavioral |
| Location | 4699 Harrison Blvd Ste 300, Ogden, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427192087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TB0200X | Psychologist - Cognitive & Behavioral | 114404-2501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John L Kluthe, PH D 4699 Harrison Blvd Ste 300, Ogden, UT 84403-4368 Ph: (801) 479-8286 | Dr John L Kluthe, PH D 4699 Harrison Blvd Ste 300, Ogden, UT 84403-4368 Ph: (801) 479-8286 |
News Archive
More than 30% of the one million heart attack victims in the United States each year die before seeking medical attention. Although widespread education campaigns describe the warning signs of a heart attack, the average time from the onset of symptoms to arrival at the hospital has remained at 3 hours for more than 10 years.
A team from University of Newcastle upon Tyne in the UK have found that the anti-cancer drug Trichostatin A (TSA), has the potential to control early labour contractions. They are optimistic the work, which is still in the early stages, will help to reduce the 70,000 premature births in the UK each year.
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.
The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis. Researchers at the University of Rochester Medical Center (URMC) have been evaluating the effects of the drug in MS for more than 10 years- it is the first medication shown to enhance some neurological functions in people with the disease - and their efforts helped pave the way for today's action by the FDA.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
› Verified 6 days ago
Dr. Jamie E Brass, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3903 Harrison Blvd Ste 300, Ogden, UT 84403 Phone: 801-387-5600 | |
Dr. Ricky D. Hawks, ED.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5677 S 1475 E, Suite 4a, Ogden, UT 84403 Phone: 801-621-6032 Fax: 801-409-0905 | |
Tayler M Wayment, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3903 Harrison Blvd Ste 300, Ogden, UT 84403 Phone: 801-387-5600 | |
Hilary Jane Jensen, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4387 Harrison Blvd Ste C4, Ogden, UT 84403 Phone: 801-387-4970 | |
Gary L Devries, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5030 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-5620 Fax: 801-475-1621 | |
Trae Mendenhall, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 237 26th St, Ogden, UT 84401 Phone: 801-625-3700 | |
Dr. Brian Dion Petrovich, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1186 E 4600 S, Ogden, UT 84403 Phone: 801-505-6545 |